Header Logo

Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.

Day JW, Mendell JR, Mercuri E, Finkel RS, Strauss KA, Kleyn A, Tauscher-Wisniewski S, Tukov FF, Reyna SP, Chand DH. Correction to: Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy. Drug Saf. 2022 Feb; 45(2):191-192.

View in: PubMed